ATE537823T1 - Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin - Google Patents
Verfahren zur behandlung von präeklampsie beim menschen mit resibufageninInfo
- Publication number
- ATE537823T1 ATE537823T1 AT05802853T AT05802853T ATE537823T1 AT E537823 T1 ATE537823 T1 AT E537823T1 AT 05802853 T AT05802853 T AT 05802853T AT 05802853 T AT05802853 T AT 05802853T AT E537823 T1 ATE537823 T1 AT E537823T1
- Authority
- AT
- Austria
- Prior art keywords
- preeclampsia
- resibufagenin
- human beings
- blood
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61996904P | 2004-10-19 | 2004-10-19 | |
PCT/US2005/034075 WO2006044107A2 (en) | 2004-10-19 | 2005-09-23 | Method of treating human preeclampsia employing resibufagenin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE537823T1 true ATE537823T1 (de) | 2012-01-15 |
Family
ID=36203374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05802853T ATE537823T1 (de) | 2004-10-19 | 2005-09-23 | Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin |
Country Status (5)
Country | Link |
---|---|
US (2) | US7759329B2 (de) |
EP (1) | EP1804789B1 (de) |
AT (1) | ATE537823T1 (de) |
CA (1) | CA2584151A1 (de) |
WO (1) | WO2006044107A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858604B2 (en) * | 2005-07-12 | 2010-12-28 | Scott & White Healthcare | Method of treating human volume expansion mediated hypertension employing resibufogenin |
US20110008904A1 (en) * | 2009-07-10 | 2011-01-13 | Scott And White Memorial Hospital And Scott, Sherwood, And Brindley Foundation | Method for determining if a patient has a traumatic brain injury and related apparatus |
US20110207154A1 (en) * | 2010-01-12 | 2011-08-25 | Scott & White Healthcare | Method for determination of marinobufagenin levels and compounds employable in such method |
RU2472506C1 (ru) * | 2011-11-07 | 2013-01-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера" Министерства здравоохранения и социального развития Российской Федерации | Способ профилактики преэклампсии |
US20180340947A1 (en) * | 2017-05-23 | 2018-11-29 | Jules B. Puschett | Involvement of the bufodienolides in the diagnosis and treatment of post-traumatic stress disorder (ptsd) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6717599A (de) | 1966-12-30 | 1968-07-01 | ||
JPS5756500A (en) * | 1980-09-22 | 1982-04-05 | Otsuka Pharmaceut Co Ltd | Novel bufadienolide-type steroid |
US5770376A (en) | 1992-12-02 | 1998-06-23 | Biomedical Sciences Research Laboratories, Inc. | Method of diagnosing and treating myocardial infarction and hypertension |
US6306845B1 (en) | 1999-01-29 | 2001-10-23 | The Trustees Of Columbia University In The City Of New York | Method for treating demyelinating disease |
CA2515012A1 (en) * | 2003-02-04 | 2004-08-26 | The Administrators Of The Tulane Educational Fund | Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus |
-
2005
- 2005-09-23 US US11/577,450 patent/US7759329B2/en not_active Expired - Fee Related
- 2005-09-23 CA CA002584151A patent/CA2584151A1/en not_active Abandoned
- 2005-09-23 EP EP05802853A patent/EP1804789B1/de active Active
- 2005-09-23 AT AT05802853T patent/ATE537823T1/de active
- 2005-09-23 WO PCT/US2005/034075 patent/WO2006044107A2/en active Application Filing
-
2010
- 2010-06-23 US US12/821,880 patent/US8080539B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1804789A2 (de) | 2007-07-11 |
WO2006044107A2 (en) | 2006-04-27 |
WO2006044107A3 (en) | 2006-10-19 |
US8080539B2 (en) | 2011-12-20 |
US7759329B2 (en) | 2010-07-20 |
US20080261928A1 (en) | 2008-10-23 |
US20100305079A1 (en) | 2010-12-02 |
EP1804789A4 (de) | 2010-06-23 |
EP1804789B1 (de) | 2011-12-21 |
CA2584151A1 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200801071A1 (ru) | Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием | |
DE60229406D1 (de) | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) | |
UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
EP2298811B8 (de) | Menschliche Anti-IFN-Gamma-neutralisierende Antikörper als selektive IFN-Gamma-Pfadhemmer | |
DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
MY140132A (en) | Thiazolidin-4-one derivatives for use in the treatment of anemias | |
HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
DE60116256D1 (de) | Zusammensetzungen zur abgabe von cortisolantagonisten | |
BRPI0512503A (pt) | composição que compreende ácido lático e lactoferrina | |
WO2007106893A3 (en) | Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors | |
ATE537823T1 (de) | Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin | |
ATE356994T1 (de) | Screeningverfahren mit pim1-kinase oder pim3- kinase | |
ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
WO2007008855A3 (en) | Method of treating human volume expansion mediated hypertension employing resibufogenin | |
WO2004071273A3 (en) | Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus | |
WO2005055956A3 (en) | Method for improving insulin sensitivity by administering an inhibitor of antitrypsin | |
DE3850728D1 (de) | Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen. | |
Shaw et al. | Hyperbaric oxygen treatment induces platelet aggregation and protein release, without altering expression of activation molecules | |
DE60319719D1 (de) | Verfahren zur voraussage der erhöhung von cholesterin während einer immunosuppresiven therapie | |
ATE484293T1 (de) | Verfahren zur vorbeugung oder behandlung von diabetes | |
ATE526984T1 (de) | Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen | |
ATE275952T1 (de) | Verfahren zur auffindung von nukleotidsyntheseinhibitoren mit weniger nebenwirkungen | |
WO2004004643A3 (en) | Interferon gamma in the detection and treatment of angiomyolipomas |